Bereavement
0
Pipeline Programs
4
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Angeles TherapeuticsCA - Los Angeles
2 programsExpressive DisclosureN/A1 trial
list of resources for griefN/A1 trial
Active Trials
Young BioPharmaMA - Lowell
1 programLong-term Consequences of Bereavement in Children, Adolescents and Young AdultsN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
Angeles Therapeuticslist of resources for grief
Angeles TherapeuticsExpressive Disclosure
Young BioPharmaLong-term Consequences of Bereavement in Children, Adolescents and Young Adults
Clinical Trials (3)
Total enrollment: 1,225,964 patients across 3 trials
Help Texts Grief Intervention for Bereaved College Students
Start: Oct 2025Est. completion: Jun 2027126 patients
N/ARecruiting
Bereaved Young Adults Study
Start: Jan 2022Est. completion: Sep 2022178 patients
N/ACompleted
NCT01453699Young BioPharmaLong-term Consequences of Bereavement in Children, Adolescents and Young Adults
Long-term Consequences of Bereavement in Children, Adolescents and Young Adults
Start: Sep 2009Est. completion: Nov 20121,225,660 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 1,225,964 patients
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.